Nanobiotix S.A. (NBTX) Earnings History
Annual and quarterly earnings data from 2011 to 2024
Loading earnings history...
NBTX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
NBTX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | 100.0% | -74.0% | -109.6% |
| 2022 | 79.4% | -977.8% | -1194.4% |
| 2021 | 100.0% | -1986.4% | -1775.7% |
| 2020 | 100.0% | -72856.0% | -67246.0% |
Download Data
Export NBTX earnings history in CSV or JSON format
Free sign-in required to download data
Nanobiotix S.A. (NBTX) Earnings Overview
As of May 8, 2026, Nanobiotix S.A. (NBTX) reported trailing twelve-month net income of -$85M, reflecting -33.3% year-over-year growth. The company earned $-1.79 per diluted share over the past four quarters, with a net profit margin of 586.9%.
Looking at the long-term picture, NBTX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$5M in fiscal 2011.
Nanobiotix S.A. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NVCR (-$173M net income, -20.8% margin), ARAY (-$46M net income, -0.3% margin), SENS (-$88M net income, -196.0% margin), NBTX has outperformed on profitability metrics. Compare NBTX vs NVCR →
NBTX Earnings vs Peers
Earnings metrics vs comparable public companies
NBTX Historical Earnings Data (2011–2024)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$68M | -71.6% | -$68M | $-1.44 | - | - |
| 2023 | -$40M | +30.4% | -$27M | $-1.08 | -109.6% | -74.0% |
| 2022 | -$57M | -21.4% | -$47M | $-1.64 | -1194.4% | -977.8% |
| 2021 | -$47M | -39.8% | -$53M | $-1.35 | -1775.7% | -1986.4% |
| 2020 | -$34M | +34.0% | -$36M | $-1.38 | -67246.0% | -72856.0% |
| 2019 | -$51M | -70.3% | -$47M | $-2.35 | -74875.0% | -68792.6% |
| 2018 | -$30M | -14.4% | -$30M | $-1.52 | -25772.4% | -25919.8% |
| 2017 | -$26M | -19.5% | -$25M | $-1.50 | -10375.6% | -10027.9% |
| 2016 | -$22M | -28.7% | -$22M | $-1.43 | -1404.3% | -1402.6% |
| 2015 | -$17M | -77.9% | -$17M | $-1.20 | -6403.1% | -6455.3% |
See NBTX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NBTX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NBTX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNBTX — Frequently Asked Questions
Quick answers to the most common questions about buying NBTX stock.
Is NBTX growing earnings?
NBTX EPS fell to $-1.79, with earnings declining -33.3%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-85M.
What are NBTX's profit margins?
Nanobiotix S.A. net margin is +586.9%, with operating margin at +589.1%. Above-average margins indicate pricing power.
How consistent are NBTX's earnings?
NBTX earnings data spans 2011-2024. The declining earnings trend is -33.3% YoY. Historical data enables comparison across business cycles.